Vodafone and Microsoft to transform the customer experience using Microsoft’s generative AI Vodafone to scale its new standalone IoT business with Microsoft Partnership will expand M-Pesa to improve financial inclusion across Africa Vodafone to grow enterprise business with new Microsoft services for small and medium-sized businesses (SMEs) Vodafone to accelerate digital transformation and operational efficiencies… Continue reading Vodafone and Microsoft sign 10-year strategic partnership to bring generative AI, digital services and the cloud to more than 300 million businesses and consumers
Category: Newswire
CELLSEARCH® CTC count proves its clinical utility in guiding therapeutic strategy supporting patient care in HR+/HER2- metastatic breast cancer
STIC CTC trial data published this November 2023 in the Journal of Clinical Oncology (JCO) demonstrate that CTC-guided treatment decision confers superior survival benefits in a subgroup of patients with hormone receptor (HR) positive)/human epidermal growth factor receptor (HER) 2 negative metastatic breast cancer (MBC), the most common subtype of newly diagnosed breast cancer. Clinical… Continue reading CELLSEARCH® CTC count proves its clinical utility in guiding therapeutic strategy supporting patient care in HR+/HER2- metastatic breast cancer
Die CTC-Zählung von CELLSEARCH® belegt ihren klinischen Nutzen bei der Festlegung der Therapiestrategie zur Unterstützung der Patientenversorgung bei metastasiertem HR+/HER2-Brustkrebs
Daten der STIC-CTC-Studie, die im November 2023 im Journal of Clinical Oncology (JCO) veröffentlicht wurden, zeigen, dass die CTC-gesteuerte Behandlung bei einer Untergruppe von Patientinnen mit Hormonrezeptor (HR)-positivem / humanem epidermalen Wachstumsfaktorrezeptor (HER)2-negativem metastasiertem Brustkrebs (MBK), dem häufigsten Subtyp von neu diagnostiziertem Brustkrebs, einen erheblichen Überlebensvorteil bietet. Die klinischen Ergebnisse dieser großen Patientenkohorte der Phase… Continue reading Die CTC-Zählung von CELLSEARCH® belegt ihren klinischen Nutzen bei der Festlegung der Therapiestrategie zur Unterstützung der Patientenversorgung bei metastasiertem HR+/HER2-Brustkrebs
International Diabetes Federation and Sanofi Global Health Unit collaborate to strengthen diabetes response in 40 countries
The partnership will enhance diabetes care through training aimed at building capacity among healthcare professionals in low and middle-income countries. BRUSSELS, Jan. 16, 2024 /PRNewswire/ — The International Diabetes Federation (IDF), in collaboration with Sanofi’s Global Health Unit (GHU), is taking significant steps to improve access to diabetes care. The collaboration aims to support the early… Continue reading International Diabetes Federation and Sanofi Global Health Unit collaborate to strengthen diabetes response in 40 countries
Significo übernimmt Piobyte und setzt seinen Weg in der Neudefinition von digitalen Gesundheitsprodukten konsequent fort.
BERLIN, 16. Januar 2024 /PRNewswire/ — Die Significo GmbH, ein Unternehmen für datenbasierte, nutzerzentrierte Gesundheitssoftware, gibt die strategische Übernahme des renommierten Softwareentwicklungsunternehmens Piobyte bekannt und setzt seinen Wachstumskurs konsequent fort. Die Übernahme erfolgt nach einer sehr erfolgreichen und langjährigen Partnerschaft. “Wir befinden uns an einem entscheidenden Punkt in unserer Mission, die Gesundheitssoftware neu zu definieren”,… Continue reading Significo übernimmt Piobyte und setzt seinen Weg in der Neudefinition von digitalen Gesundheitsprodukten konsequent fort.
Cisco and OECD Launch Pioneering Research Initiative on Digital Well-being
Cisco to co-develop with the OECD WISE Centre an interactive knowledge hub to help understand technology’s role in fostering inclusion and improving well-being News Summary: The rapid pace of digital transformation and advancements in AI merit a global discussion on how people experience technological change. Technology can be a force for good, but it can… Continue reading Cisco and OECD Launch Pioneering Research Initiative on Digital Well-being
CELLSEARCH® CTC count proves its clinical utility in guiding therapeutic strategy supporting patient care in HR+/HER2- metastatic breast cancer
STIC CTC trial data published this November 2023 in the Journal of Clinical Oncology (JCO) demonstrate that CTC-guided treatment decision confers superior survival benefits in a subgroup of patients with hormone receptor (HR) positive)/human epidermal growth factor receptor (HER) 2 negative metastatic breast cancer (MBC), the most common subtype of newly diagnosed breast cancer. Clinical… Continue reading CELLSEARCH® CTC count proves its clinical utility in guiding therapeutic strategy supporting patient care in HR+/HER2- metastatic breast cancer
International Diabetes Federation and Sanofi Global Health Unit collaborate to strengthen diabetes response in 40 countries
The partnership will enhance diabetes care through training aimed at building capacity among healthcare professionals in low and middle-income countries. BRUSSELS, Jan. 16, 2024 /PRNewswire/ — The International Diabetes Federation (IDF), in collaboration with Sanofi’s Global Health Unit (GHU), is taking significant steps to improve access to diabetes care. The collaboration aims to support the early… Continue reading International Diabetes Federation and Sanofi Global Health Unit collaborate to strengthen diabetes response in 40 countries
TAT Technologies signs another 5-year contract with an international air carrier for APU MRO services with estimated total revenues of $10 million
NETANYA, Israel, Jan. 16, 2024 /PRNewswire/ — TAT Technologies Ltd. (TASE: TATT) (NASDAQ: TATT), a leading supplier of products and services for the commercial and military aviation industries and the ground defense industries, announces a new contract with an international air carrier. This contract is a result of a very successful partnership between the companies… Continue reading TAT Technologies signs another 5-year contract with an international air carrier for APU MRO services with estimated total revenues of $10 million
El recuento de CTC de CELLSEARCH® demuestra su utilidad en cáncer de mama metastásico HR+/HER2-
El recuento de CTC de CELLSEARCH® demuestra su utilidad clínica en la orientación de la estrategia terapéutica y el cuidado del paciente en cáncer de mama metastásico HR+/HER2-. Los datos del ensayo STIC CTC publicados este noviembre de 2023 en el Journal of Clinical Oncology (JCO) demuestran que la decisión de un tratamiento guiado por CTC… Continue reading El recuento de CTC de CELLSEARCH® demuestra su utilidad en cáncer de mama metastásico HR+/HER2-